1808.40↑45.35 (2.57%)
12:00 AM,29th Sep 20231809.85↑49.80 (2.83%)
12:00 AM,29th Sep 2023BSE : 530199
NSE : THEMISMED
Sector : Health care
ISIN Code : INE083B01016
Last Updated: Sep 29 2023 | 12:00 AM IST
Market Cap (₹ Cr) | 1663 |
Turnover (₹ Cr) | 0.25 |
Volume (Shares) | 13892 |
Face Value | 10 |
52-WK High | 1834.00 |
52-WK High Date | 29 Sep 2023 |
52-WK Low | 877.65 |
52-WK Low Date | 18 Nov 2022 |
All Time High | 1834.00 |
All Time High Date | 29 Sep 2023 |
All Time Low | 40.00 |
All Time Low Date | 04 Sep 2013 |
Incorporated in 1969 Themis Medicare Ltd. formerly known as Themis Chemicals (TCL) was originally promoted by Chemosyn and Medimpex but was taken over by a group consisting of Shantibhai D Patel and K T Lakdawala who also have interests in Andhra Synthetics and Antibiotics which was merged with Artemis Pharmaceuticals in April 93.In Mar.'95 the company came out with a public issue equity shares (premium : Rs 110) to finance the expansion-cum-modernisation of its synthetic bulk drug plant at Vapi the setting up of a formulation unit at Lilora Baroda as backward integration and to augment long-term working capital.Total cost of the project was estimated at Rs 17.64 cr. TCL manufactures and sells synthetic bulk drugs and formulations. It operates in the therapeutic segments of anti-tuberculosis cerebroactivators bronchodilators anti-asthmatic anaesthetic and other segments.Anti-tuberculosis bulk drugs and formulations account for 60% of its turnover and the company is rated fourth in terms of turnover in this segment. TCL has also started manufacturing and exporting fumagillin an anti-bacterial drug for veterinary use for which it has a confirmed buy-back arrangement with Chinoin Hungary.The company with the help of M/s PharmogradMoscow a manufacturing unit is planning to market its Anti-T.B.formulation products through the collborators throughout the Russian Federation for tradetenders and govt.supplies.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 1663 |
EPS - TTM (₹) [S] | 48.05 |
P/E Ratio (X) [S] | 6.71 |
Face Value (₹) | 10 |
Latest Dividend (%) | 50.00 |
Latest Dividend Date | 01 Sep 2023 |
Dividend Yield (%) | 0.28 |
Book Value Share (₹) [S] | 269.54 |
P/B Ratio (₹) [S] | 6.71 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|---|---|---|
Motilal Oswal S&P BSE Healthcare ETF | 0.00 | 31 | 0.06 |
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 1741.95 1834.00 |
Week Low/High | 1688.15 1834.00 |
Month Low/High | 1560.00 1834.00 |
Year Low/High | 877.65 1834.00 |
All time Low/High | 12.00 1834.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 4.99% | 4.95% | -0.27 | -0.18% |
1 Month | 12.99% | 13.23% | 1.16 | 1.53% |
3 Month | 31.08% | 31.68% | 2.99 | 3.51% |
6 Month | 63.43% | 62.77% | 14.26 | 15.85% |
1 Year | 80.61% | 80.11% | 16.70 | 16.77% |
3 Year | 439.10% | 439.18% | 73.35 | 74.99% |
Date | Client Name | Exchange | Transaction | Quantity | Price |
---|---|---|---|---|---|
02-06-2021 | TEJAS TRADEFIN LLP | NSE | BUY | 72009 | 735.76 |
12-03-2013 | ANUJ ANANTRAI SHETH | BSE | BUY | 112500 | 60.25 |
12-03-2013 | GAGANDEEP CREDIT CAPITAL PRIVATE LIMITED | BSE | SELL | 112500 | 60.25 |
26-03-2010 | KISHORCHAND RATULSIDAS LAKDAWALA | BSE | SELL | 235712 | 181.50 |
26-03-2010 | THEMIS DISTRIBUTORS PVT. LTD. | BSE | BUY | 234612 | 181.50 |
04-03-2010 | DINESH SHANTILAL PATEL | BSE | BUY | 241712 | 175.00 |
04-03-2010 | KISHOR CHANDRA TULSIDAS LAKDAWALA | BSE | SELL | 89976 | 175.00 |
04-03-2010 | RANJANBEN KISHORE CHANDRA LAKDAWALA | BSE | SELL | 133536 | 175.00 |
Name | Price(In Rs) | Chg(%) | Mkt Cap(Rs Cr) | Sales(Rs Cr) | Profit(Rs Cr) | EPS(Rs) | P/E(x) |
---|
Category | Share(%) |
---|---|
Promoter | 67.16 |
Financial Institutions Banks | 0.01 |
Foreign Institutional Investors | 0.04 |
Insurance Companies | 0.00 |
Mutual Funds Uti | 0.00 |
Other Institutional Investors | 0.00 |
Indian Public | 22.64 |
Others Non Institutional Investors | 10.15 |
Custodians | 0.00 |
Announcement Date | Purpose | From | To | Remarks |
---|---|---|---|---|
Data Not Found |
Search for Price History
Date | Open | High | Low | Close | Shares | Trades |
---|---|---|---|---|---|---|
Data Not Found |
Load more
Non-Exec & Non-Independent Dir : Rajneesh Anand
Independent Non Exe. Director : VIJAY GOPI KISHAN AGARWAL
Independent Non Exe. Director : Hari Subramaniam
Non Executive Director : Reena S Patel
ED / MD / CEO / Promoter : Sachin D Patel
Chairman & Independent Directo : Dinesh S Patel
Independent Non Exe. Director : Manjul Sandhu
Independent Non Exe. Director : Bhaskar Vemban Iyer
Additional Director : Shishir Dalal
Alternate Director : Reena S Patel
Registered Office: Plot No 69 A GIDC Indl Estate, Vapi,Valsad,Gujarat-396195 Ph: 91-260-2421675